DEF 14A

Company

TScan Therapeutics, Inc.

Filed

April 30, 2024

Period of Report

June 12, 2024

Accession Number

0001193125-24-125066

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →